The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, J.
Right arrow Articles by Beller, D. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, J.
Right arrow Articles by Beller, D. I.
The Journal of Immunology, 2003, 170: 4489-4496.
Copyright © 2003 by The American Association of Immunologists

Distinct Pathways for NF-{kappa}B Regulation Are Associated with Aberrant Macrophage IL-12 Production in Lupus- and Diabetes-Prone Mouse Strains1

Jiajian Liu2 and David I. Beller2

Arthritis Section, Evans Department of Medicine and Clinical Research, Boston University Medical Campus, Boston, MA 02118

One characteristic of mice prone to a variety of autoimmune diseases is the aberrant regulation of cytokine production by macrophages (M{phi}), noted in cells isolated well before the onset of disease. Strikingly, the pattern of IL-12 dysregulation, in particular, is consistent with the nature of the autoimmune disease that will develop in each strain, i.e., elevated in mice prone to Th1-mediated organ-specific disease (nonobese diabetic (NOD) and SJL mice) and reduced in lupus-prone strains (MRL/+ and NZB/W). Mechanistically, the abnormal regulation of IL-12 in these strains was found to be strictly associated with novel patterns of Rel binding in vitro to the unique NF-{kappa}B site in the IL-12 p40 promoter. In this study, we report several new findings related to these Rel-{kappa}B interactions. Evaluation of the p40 NF-{kappa}B site in vivo, assessed by chromatin immunoprecipitation, revealed Rel usage patterns similar to those found in vitro using EMSA, with preferential association of the p40 {kappa}B site with c-Rel in NOD M{phi} but with p50 in NZB/W M{phi}. Moreover, blocking c-Rel in primary M{phi}, using short interfering RNA, selectively blocked IL-12 production and normalized the minimal, residual IL-12 levels. Nuclear extracts from NOD M{phi} were characterized by c-Rel hyperphosphorylation, and dephosphorylation of nuclear proteins completely blocked binding to the {kappa}B site. In contrast, elevated I{kappa}B appears to be a likely mechanism accounting for the reduced nuclear c-Rel levels noted in NZB/W M{phi}. Alterations in NF-{kappa}B metabolism thus appear to define a pathway regulating intrinsic IL-12 defects in both diabetes- and lupus-prone strains.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. H. Esensten, M. R. Lee, L. H. Glimcher, and J. A. Bluestone
T-bet-Deficient NOD Mice Are Protected from Diabetes Due to Defects in Both T Cell and Innate Immune System Function
J. Immunol., July 1, 2009; 183(1): 75 - 82.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. Marleau, K. L. Summers, and B. Singh
Differential Contributions of APC Subsets to T Cell Activation in Nonobese Diabetic Mice
J. Immunol., April 15, 2008; 180(8): 5235 - 5249.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. McDuffie, N. A. Maybee, S. R. Keller, B. K. Stevens, J. C. Garmey, M. A. Morris, E. Kropf, C. Rival, K. Ma, J. D. Carter, et al.
Nonobese Diabetic (NOD) Mice Congenic for a Targeted Deletion of 12/15-Lipoxygenase Are Protected From Autoimmune Diabetes
Diabetes, January 1, 2008; 57(1): 199 - 208.
[Abstract] [Full Text] [PDF]


Home page
Adv. Physiol. Educ.Home page
E. Dale, M. Davis, and D. L. Faustman
A role for transcription factor NF-{kappa}B in autoimmunity: possible interactions of genes, sex, and the immune response
Advan Physiol Educ, December 1, 2006; 30(4): 152 - 158.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Cao, X. Zhang, J. P. Edwards, and D. M. Mosser
NF-{kappa}B1 (p50) Homodimers Differentially Regulate Pro- and Anti-inflammatory Cytokines in Macrophages
J. Biol. Chem., September 8, 2006; 281(36): 26041 - 26050.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Liu, H. Wang, Y. Zuo, and S. R. Farmer
Functional Interaction between Peroxisome Proliferator-Activated Receptor {gamma} and {beta}-Catenin
Mol. Cell. Biol., August 1, 2006; 26(15): 5827 - 5837.
[Abstract] [Full Text] [PDF]


Home page
Clin. DiabetesHome page
J. H. Southerland, G. W. Taylor, and S. Offenbacher
Diabetes and Periodontal Infection: Making the Connection
Clin. Diabetes, October 1, 2005; 23(4): 171 - 178.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Hoentjen, R. B. Sartor, M. Ozaki, and C. Jobin
STAT3 regulates NF-{kappa}B recruitment to the IL-12p40 promoter in dendritic cells
Blood, January 15, 2005; 105(2): 689 - 696.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Liu and S. R. Farmer
Regulating the Balance between Peroxisome Proliferator-activated Receptor {gamma} and {beta}-Catenin Signaling during Adipogenesis: A GLYCOGEN SYNTHASE KINASE 3{beta} PHOSPHORYLATION-DEFECTIVE MUTANT OF {beta}-CATENIN INHIBITS EXPRESSION OF A SUBSET OF ADIPOGENIC GENES
J. Biol. Chem., October 22, 2004; 279(43): 45020 - 45027.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. H. Koonce and E. K. Bikoff
Dissecting MHC Class II Export, B Cell Maturation, and DM Stability Defects in Invariant Chain Mutant Mice
J. Immunol., September 1, 2004; 173(5): 3271 - 3280.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Xiong, C. Zhu, F. Li, R. Hegazi, K. He, M. Babyatsky, A. J. Bauer, and S. E. Plevy
Inhibition of Interleukin-12 p40 Transcription and NF-{kappa}B Activation by Nitric Oxide in Murine Macrophages and Dendritic Cells
J. Biol. Chem., March 12, 2004; 279(11): 10776 - 10783.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.